Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Baaske, D.
Right arrow Articles by Sigvardson, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baaske, D.
Right arrow Articles by Sigvardson, K.
American Journal of Health-System Pharmacy, Vol 53, Issue 14, 1701-1705
Copyright © 1996 by American Society of Health-System Pharmacists


Articles

Stability of nicardipine hydrochloride in intravenous solutions

DM Baaske, JF DeMay, CA Latona, S Mirmira, and KW Sigvardson


The stability of nicardipine hydrochloride in large-volume i.v. solutions was studied. Admixtures of nicardipine hydrochloride 0.05 and 0.5 mg/mL were prepared in 5% dextrose and 0.45% sodium chloride injection, 5% dextrose and 0.9% sodium chloride injection, 0.45% sodium chloride injection, 0.9% sodium chloride injection, 5% dextrose and lactated Ringer's injection, 5% dextrose injection, lactated Ringer's injection, 5% sodium bicarbonate injection, and 5% dextrose injection with potassium chloride 40 meq/L. Two glass and two polyvinyl chloride (PVC) containers of each solution were prepared and stored at ambient room temperature under normal fluorescent light. Samples were removed and tested for nicardipine concentration by stability-indicating high-performance liquid chromatography at 0, 24, 48, and 72 hours and seven days. Testing included visual checking and optical density measurements. The admixtures remained clear and slightly yellow except for nicardipine hydrochloride in sodium bicarbonate injection, which showed immediate precipitation, and nicardipine hydrochloride in lactated Ringer's injection, which increased in optical density at 400 nm over time. There were no significant changes in nicardipine concentrations in nicardipine concentrations in glass containers. Admixtures stored in PVC containers showed a slow, constant decline in nicardipine concentrations, sometimes to less than 85% of the initial drug concentration within 24 hours, except for nicardipine hydrochloride in lactated Ringer's injection or 5% dextrose and lactated Ringer's injection, which showed an immediate and continuing rapid loss. Nicardipine hydrochloride 0.5 and 0.05 mg/mL in eight i.v. solutions was stable in glass containers for up to seven days. Drug concentrations slowly decreased in PVC containers. The drug was not stable in 5% sodium bicarbonate injection or in PVC bags containing lactated Ringer's injection or 5% dextrose and lactated Ringer's injection.
 






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society of Health-System Pharmacists.